MFS
IOVA icon

Mirabella Financial Services’s Iovance Biotherapeutics IOVA Stock Holding History

Mirabella Financial Services’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,773
Closed -$87K – 931
2026
Q1 		$87K Buy
+24,773
New +$79.2K 0.01% 867
2021
Q1 		– Sell
-6,400
Closed -$297K – 350
2020
Q4 		$297K Buy
+6,400
New +$254K 0.04% 212

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Mirabella Financial Services's IOVA Position: Q2 2026 in Review

Mirabella Financial Services sold out of Iovance Biotherapeutics (IOVA) in Q2 2026, closing a stake of 24,773 shares — an estimated $87K sold.

Mirabella Financial Services first reported a position in IOVA in Q4 2020 and held it in 2 quarters. The position peaked at $297K in Q4 2020. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Mirabella Financial Services reported no remaining Iovance Biotherapeutics position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 24,773 Iovance Biotherapeutics shares in Q2 2026, an estimated $87K.
  • Mirabella Financial Services first reported a position in Iovance Biotherapeutics in Q4 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Iovance Biotherapeutics position peaked at $297K in Q4 2020.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.